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induction of DUSP-1 gene expression was mediated by EP2/EP4 re-
ceptors coupled to both the protein kinase A and p38 MAP kinase
pathways. In the dorsal air-pouch mouse model of synovial inﬂammation,
LPS-treatments provoked air pouch edema and signiﬁcant leukocyte
inﬁltration (predominantly neutrophils, CDw17 and monocytes, CD11c)
after 6−24 h, with concomitant increases in TNF-a, Il-1b, MIP-1a, MMP-8,
MMP-9, and MMP-13 levels in the exudates. Pre-treatment (30min) with
1mmol/L of PGE2 or PGE2 mimetics like forskolin/rolipram reduced LPS-
induced leukocyte inﬁltration by 42±5% (mean±SD) while TNF-a, MIP-
1a, MMP-9, and MMP-13 expression levels fell by 67 to 91% on average.
PGE2-dependent suppression of induced leukocyte inﬁltration and MMP-
9/TNF-a expression were abrogated in DUSP-1 null (−/−) mice.
Conclusions: We conclude that PGE2-dependent modulation of molec-
ular and cellular components of the inﬂammatory/proliferative/catabolic
response is mediated, at least in part, by DUSP-1. DUSP-1 may be
a promising drug target for modulating MAPK-dependent proliferative
responses in arthritis, infectious diseases and cancers.
439 MITOCHONDRIAL DYSFUNCTION ACTIVATES
CYCLOOXYGENASE-2 EXPRESSION IN CULTURED NORMAL
HUMAN SYNOVIOCYTES
N. Valcarcel-Ares, C. Vaamonde-Garcia, R. Riveiro-Naviera, L. Hermida,
B. Lema, F.J. Blanco, M.J. Lopez-Armada. INIBIC-CH Universitario Juan
Canalejo, A Corun˜a, SPAIN
Purpose: Prostaglandin E2 (PGE2) plays a profound role in the
pathogenic processes of rheumatoid arthritis (RA). Recently, it has been
reported that mitochondrial alterations may contribute to the progression
of RA. In this study, we have investigated the relationship between the
dysfunction of mitochondrial respiratory chain (MRC) and the in vitro
expression of COX-2 in cultured normal human synoviocytes.
Methods: Normal human synoviocytes were isolated from knee synovium
obtained from necropsy from 9 adult cadavers (mean age 43 years). Com-
monly used inhibitors of the MRC were employed to induce mitochondrial
dysfunction. Rotenone (1 and 10mg/ml), 3-nitropropionic acid (0.5, 2 and
10mM), Antimycin A (AA: 5, 10 and 20 mg/ml), Sodium azide (2, 10 and
25mM) and Oligomycin (5, 10 and 25mg/ml) were employed as inhibitor
of the complex I, II, III, IV and V of MRC, respectively. Protein and mRNA
COX-2 expression were analyzed by cytometry and real time PCR. PGE2
levels were evaluated by ELISA. As a positive control, COX-2 expression
was induced by Il-1b (1 ng/ml).
Results: Firstly, only the exposure of synoviocytes to AA and oligomycin
signiﬁcantly increased COX-2 protein expression in a time- and dose
dependent manner. The maximal response was observed at 6 h with
a concentration of 20mg/ml AA and 25mg/ml oligomycin (15.4±3.3 and
28.2±10.8 respectively vs. basal 3.6±0.6, n = 6). At the same time, the
positive control, 1 ng/ml Il-1b, induced a COX-2 protein expression of
45±12.6. When the percentage of cells that expressed COX-2 mRNA
was examined by real time RT-PCR the results obtained at 4 h of stim-
ulation were consistent with those of protein expression (30- and 40-
fold increase for 20mg/ml AA and 25mg/ml oligomycin, respectively, vs.
basal 1). The positive control, 1 ng/ml Il-1b, induced a level of COX-2
mRNA expression of 787-fold increase. When the production of PGE2 at
24 h was assessed similar results were obtained (72±23 and 99±38 for
AA and oligomycin, respectively vs. basal 23±1). Secondly, we tested if
mitochondrial dysfunction induced by AA or oligomycin could modulate
the response induced by Il-1b (1 ng/ml) on COX-2 protein expression.
We found that pre-treatment of synoviocytes with either 5 mg/ml AA or
10mg/ml oligomycin for 30 minutes increases signiﬁcantly the expression
of COX-2 induced by Il-1b (1 ng/ml) at protein levels. The values of COX-2
protein expression were 104.7±38.6 for AA + Il-1b and 96.4±24.4 for
oligomycin + Il-1b vs. 45.0±12.6 for Il-1b (n = 6, p< 0.05).
Conclusions: These results showed that the dysfunction of mitochondrial
respiratory activity induces an inﬂammatory response in synoviocytes
contributing to the chronic inﬂammation of synovial tissue in RA and
aging joint. These data may prove valuable for a better understanding
of the participation of mitochondria in the pathogenesis of RA synovium.
440 ELEVATED LEVELS OF INFLAMMATORY MEDIATOR
PROSTAGLANDIN E2 (PGE2) IN EX-VIVO CULTURED
PERIPHERAL BLOOD LEUKOCYTES (PBL) OF
OSTEOARTHRITIS (OA) PATIENTS
M. Attur, S. Krasnokutsky, I. Belitskaya-Levy, M. Dave, J. Patel,
J. Samuels, P. Rosenthal, S.B. Abramson. NYU Hospital for Joint
Diseases, New York, NY, USA
Purpose:OA is a degenerative joint disease causing loss of joint function,
pain and physical disability. The diarthrodial joint’s diseased tissues
(bone, cartilage, synovium) are sites of production of cytokines (e.g., Il-1b,
TNF-a) and inﬂammatory mediators (e.g., prostaglandins, nitric oxide).
We hypothesize that circulating blood cells, exposed to inﬂammatory
mediators as they perfuse the OA joint, may act as sensors reﬂecting OA
disease activity and/or burden. In the current study we explored whether
PBL from OA patients are primed to produce increased inﬂammatory
mediators compared to PBL from healthy controls.
Methods: We recruited 56 patients with knee OA and 8 age-matched
healthy controls.). QRT-PCR was performed using Applied Biosystems.
PGE2 levels were measured by ELISA (Cayman) from stored plasma
samples.
Results: OA patients produced moderately higher levels of PGE2 than
healthy controls in unstimulated plasma at baseline (p = 0.081). However,
when whole blood from both OA and controls was cultured (24 h) ex
vivo (100 and 94 pg/ml respectively), PGE2 in controls did not change,
while levels in OA patients increased 300% over baseline (p< 0.01). The
increased PGE2 production at 24 hr ex vivo suggested that OA PBLs may
be primed or activated in vivo. We therefore examined mRNA (QPCR)
expression of PBL COX-2, Il-1b and TNFa. Each of these transcripts
were elevated in OA patients (p< 0.02) compared to controls. PBL levels
of Il-1b in OA correlated with TNFa levels (r = 0.43, p = 0.003); increased
COX-2 expression correlated weakly with TNFa expression (r = 0.213,
p< 0.0003). When stratifying these inﬂammatory mediator levels in OA
patients by NSAID use, we observed higher levels of both baseline PGE2
(p< 0.04) and Il-1b mRNA (p=0.04) in NSAID users compared with non-
users. Finally, we asked whether evidence of PBL activation correlated
with radiographic ﬁndings. PBL PGE2 production signiﬁcantly correlated
with semi-quantitative subchondral sclerosis scores (r = 0.37, p< 0.013)
and negatively correlated with osteophyte scores (r = −0.268, p< 0.05).
PGE2 levels trended to correlate with increasing KL scores (p = 0.1).
Relative expression levels of Il-1b but not TNFa moderately correlated
(r = 0.263, p< 0.05) with WOMAC pain score and not with any other x-ray
ﬁndings. (p = 0.4).
Conclusions: OA PBL produce higher levels of PGE2 than do age-
matched controls. PGE2 production is associated with increased PBL
expression of mRNA for COX-2, Il-1b and TNF-a. These data indicate that
PBL are activated by exposure to inﬂammatory stimuli as they circulate
through the diseased synovium and bone in patients with OA. We propose
that activated PBL can serve as biomarkers for disease activity in OA
and may predict patients at risk for disease progression. Whether the
activation of PBL confers a risk of endothelial injury and vascular disease
over time merits additional evaluation.
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EARLY AND END-STAGE OSTEOARTHRITIS
C.R. Scanzello1, E. Umoh1, T. Miles2, H.G. Potter1, R. Marx1,
S. Rodeo1, S.R. Goldring1, M.K. Crow1. 1Hospital for Special Surgery,
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Purpose: Innate immune system activation has been implicated in os-
teoarthritis (OA) pathogenesis, but much of what we know about the
synovial inﬂammatory response in this prevalent joint disease is derived
from studies of end-stage patients. In this study, we sought to better
characterize cytokine production in patients with early signs of knee OA,
focusing on the common gamma chain cytokines Il-15 and Il-21, important
mediators linking the innate and adaptive immune response.
Methods: Synovial membrane (SM) and ﬂuid (SF) specimens were col-
lected from patients with degenerative meniscal tears and early cartilage
degeneration undergoing arthroscopic procedures (early OA) and pa-
tients undergoing total knee replacement for end-stage OA. Quantitative
real-time PCR was used to compare expression of SM cytokines and
cell lineage-speciﬁc markers. SF cytokine and matrix-metalloproteinase
(MMP-1 and MMP-3) levels (proteases implicated in cartilage extracellular
matrix remodeling) were quantiﬁed by ELISA. Transcript and protein
levels were compared in early and end-stage specimens, using the
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Mann-Whitney t-test. Correlations between cytokines, proteases, and cell-
lineage markers were detected using Spearman’s correlation test.
Results: SM Il-15 mRNA and SF protein levels were detectable in all
early OA patients (18 SM and 11 SF), and in most end-stage patients as
well (11/13 SM and 9/10 SF); furthermore protein levels were elevated
in the early knee OA patients when compared to end-stage (p = 0.0004).
In contrast, SM Il-21 mRNA levels were detectable in 11/18 early OA
patients and in all end-stage patients, while SF protein levels were
measurable in 7/10 end-stage and 5/9 early OA patients. Il-21 mRNA and
protein levels did not differ in the two patient groups. In early OA patients,
Il-15 transcript levels within the tissue were associated with CD8 transcript
levels (r = 0.508, p = 0.04), and Il-21 mRNA levels correlated with CD19
(r = 0.746, p = 0.0009) and CD56 (r = 0.742, p = 0.0015) expression, con-
sistent with the known effects of these cytokines on speciﬁc lymphocyte
subsets. Il-15 transcript levels were associated with both Il-21 mRNA
(r = 0.445, ns trend p=0.08) and protein levels (r = 0.783, p = 0.017), sug-
gesting coordinate regulation of these two cytokines. Finally, increasing
SF Il-15 was positively associated with both total (r = 0.582, p = 0.023)
and active (r = 0.576, p = 0.025) SF MMP-1 concentration.
Conclusions: The common-gamma chain cytokines, Il-15 and Il-21, are
produced within the joint in the majority of patients with end-stage knee
OA, as well as in patients with degenerative meniscal tears and signs
of early cartilage degeneration. Furthermore, Il-15 levels are elevated
in early knee OA, implicating innate immune system activation early in
the disease process. The association of Il-15 with MMP-1 implicates this
cytokine in extracellular matrix remodeling in OA.
442 ACTIVITY AND EXPRESSION OF HYALURONIDASES
ASSOCIATED WITH HYALURONAN SYNTHASES
EXPRESSION AND CHANGE OF MOLECULAR WEIGHT OF
HYALURONAN IN THE JOINT FLUID
M. Uzuki1, Y. Sasaki1, S. Tokunaga1, A. Kamataki1, K. Nomi2,
H. Kitagawa2, J. Kaiyama3, T. Sawai1. 1Iwate Medical University, School
of Medicine, Morioka, Iwate, JAPAN, 2Denki Kagaku Kogyo Co, LTD,
Machida, JAPAN, 3Iwate Prefectural Isawa Hospital, Ohsyu, Iwate,
JAPAN
Purpose: Hyaluronidase (Hyal) and hyaluronic acid synthase (HAS) were
cloned in human recently. HAS-1 and HAS-2 synthesize high molecular
weight (2×106 Da) hyaluronic acid (HA), while HAS-3 synthesizes low
molecular weight one (2×105 Da). It has been obscure why the molec-
ular weight of HA in synovial ﬂuid (SF) decreases in the patients with
rheumatoid arthritis (RA). In order to study the relationship between
the expression patterns of Hyals, HASs, Hyal activity and HA molecular
weight in SF, we examined the expression of these enzymes in the
articular tissue of patients with RA.
Methods: Synovial tissues/ﬂuids were obtained from 58 patients with
RA at various stage of inﬂammation, 27 patients with osteoarthritis and
6 with trauma. We studied Hyals (Hyal-1, -2, -3) and HASs (HAS-1,
-2, -3) expression by using mRNA in situ hybridization analysis and
immunohistochemistry. In addition, we investigated Hyal activity in SF
samples by HA substrate gel enzyme zymography. Then we examined
HA molecular weight in SF by HPLC.
Hyaluronidase activity and molecular weight of HA in SF.
Results: Hyals were detected in synoviocytes. The number of positive
cells of Hyals was higher in RA active stage than in non-inﬂamed control
patients. Utilizing Hyal enzyme zymography, the enzyme activity of Hyal
in synovial ﬂuid was higher in the active stage of RA than in the ﬁbrotic
one. There was negative correlation between Hyal activity and molecular
weight of HA in SF (r = −0.55, p< 0.005) (Fig). The enzyme activity of Hyal
in SF was positively correlated with the number of positive cells of Hyals
mRNA in synovial tissues. HAS-1, -2 were detected in synoviocytes. On
the other hand, HAS-3 was detected in synoviocytes and inﬂammatory
cells. The number of positive cells of HAS-1 and HAS-2 was lower
in RA advanced stage although that of HAS-3 positive cells reached
maximum level in the active inﬂammatory stage. Moreover, the number
of HAS-3 positive cells was negatively correlated with the HA molecular
weight in synovial ﬂuid (r = −0.51, p< 0.005) and positively correlated
with histologically deﬁned local inﬂammatory activity in RA (r = 0.563,
p< 0.005).
Conclusions: The results suggest that HA may be actively synthesized
by HAS-1 or HAS-2 in early stage of RA and become to smaller size
by HAS-3 products and degeneration by Hyals in inﬂammatory stage of
RA. The number and distribution of Hyals and HASs can be affected by
synovial inﬂammation.
443 GENERATION OF OSTEOARTHRITIS-LIKE CYTOKINE
PROFILES USING AN IN VITRO CO-CULTURE MODEL
P. DiBenedetto, M. DiMicco, F. Chen, Q. Yu, G. Matthews. Genzyme
Corporation, Framingham, MA, USA
Purpose: There are many in vitro systems for studying cartilage degen-
eration, but most do not model interactions between the various cell types
in a joint. We developed an in vitro model of cartilage degradation using
cells that are representative of those found in osteoarthritic joints. Our
goal was to generate a compositional proﬁle similar to that found in OA
synovial ﬂuid (as distinct from that in inﬂammatory conditions, such as
rheumatoid arthritis) that would lead to cartilage degeneration.
Methods: Synovial ﬁbroblasts (Type B cells), isolated from a 68-year-
old normal donor, were cultured overnight at 2.5×104/cm2 in 24-well cell
culture inserts in medium containing DMEM with 10% FBS and 50 ug/ml
Gentamicin. The next day, premonocytic U937 cells, representing synovial
Type A cells, were added to the insert at 1.0×105/cm2. The two cell types
were cultured together for 3 days, promoting differentiation of the U937
cells into monocytes. After 3 days, medium was changed to be serum-free
and 6mm full-thickness cartilage discs isolated from 6-month-old calves
were added to the wells containing the cell-laden inserts. To stimulate
the system with potential mediators of OA, cultures were treated with the
N-terminal 30 kDa ﬁbronectin fragment (Fn-f, 0.8 mM) or urokinase-type
plasminogen activator (uPa, 15 nM). Il-1b treatment (5 ng/mL) was used
as a positive control. To study the speciﬁc effects of Il-1 on stimulated co-
cultures, some samples were preincubated with 1.4 nM Il-1ra for 4 hours
before stimulation. After 7 days, medium was assessed for sGAG content
(DMMB), and for Il-1b, Il-1ra, Il-10, Il-6, Il-8, RANTES, TNFa and MMP-1,
-3, and -13 (Luminex xMAP). GAG was also determined in cartilage discs
(DMMB, and Safranin O histology).
